Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults

BACKGROUND: We aimed to compare the steady-state pharmacokinetic parameters and tolerability of Triomune 40® (stavudine 40 mg, lamivudine 150 mg and nevirapine 200 mg) and branded formulations of these drugs in HIV-infected Ugandans. METHODS: This includes a randomized, open-label, cross-over study...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Byakika-Kibwika, Pauline, Lamorde, Mohammed, Kalemeera, Francis, D’Avolio, Antonio, Mauro, Sciandra, Di Perri, Giovanni, Ryan, Mairin, Mayanja-Kizza, Harriet, Khoo, Saye, Back, David, Boffito, Marta, Merry, Concepta
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3596856/
https://ncbi.nlm.nih.gov/pubmed/18641036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkn290
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires